Menu

Moderna, Inc. MRNA

Full chart Compare
Set alert

Price alert · MRNA

All alert types
254.19 USD +12.73 (+5.27%)

At closeNov 6, 2026, 7:56 PM EST

256.92 +2.73 +1.07%

After hours · Nov 6, 7:56 PM ET

237.86 Day range 267.50
22.36 52-week range 258.38
YTD
+761.95%
1 year
+944.76%

Discussion (2977)

Sign in to join the discussion

Member MRNA 1 day ago #1

Take that bear, glad I didn’t listen to you guys😀

Member MRNA 3 days ago #2

Dow 1000 points take that you fuck face tariff prick 😂😂😂😂😂

Circular Reference MRNA 1 week ago #3

One potential longer-term tailwind for Iovance that deserves investor attention is California’s proposed $8.4 billion Proposition 38 bond measure. It includes $4.2 billion for a UCLA-affiliated immunology and immunotherapy research institute and another $4.2 billion for competitive research grants.

While Iovance would not qualify for direct grants as a for-profit company, the funding could create opportunities for academic partnerships, TIL research, clinical trial infrastructure and collaboration with commercial cell-therapy developers.

Given Iovance’s existing California clinical trial footprint and its leadership in tumor-infiltrating lymphocyte (TIL) therapy, the scientific alignment is particularly interesting.

Bunny Bun MRNA 1 week ago #8

Dropped -10% still in green :)